Ligand targeting allows selective delivery of therapeutic and imaging agents to cancer cells while avoiding collateral damage to healthy tissues. Small-molecule–ligand conjugates more readily ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback